$0.25
-10.81%
N/A-$0.03
Healthcare
Biotechnology
NASDAQ
활발히 거래 중
GT Biopharma, Inc. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and bringing to market novel immuno-oncology treatments. ...
GT Biopharma, Inc. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and bringing to market novel immuno-oncology treatments. ...
C-레벨 임원은 회사의 재무 전략과 혁신을 이끄는 응집된 리더십 팀입니다.
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
| Michael Martin Breen | President, CEO & Executive Chairman | USD 1,385,647 | 1963 | Active | |
| Alan Louis Urban | Chief Financial Officer & Secretary | USD 626,310 | 1968 | Active |
| Filing Date | Year | Name | Position | Level | Salary | Bonus | Stock Award | Option Award | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 | 2025 | Michael Breen Chairman, | Chief Chief Executive Officer, and President President | Founder / CEO | $641.02K | $585.06K | $0 | $342.00K | $0 | $159.57K | $1.73M |
| 2026-07-02 | 2025 | Alan Urban | Chief Chief Financial Officer | C-Level | $393.75K | $157.50K | $0 | $113.00K | $0 | $75.06K | $739.31K |
| 2026-07-02 | 2024 | Michael Breen Chairman, | Chief Chief Executive Officer, and President President | Founder / CEO | $556.20K | $417.15K | $0 | $0 | $0 | $213.62K | $1.19M |
| 2026-07-02 | 2024 | Alan Urban | Chief Chief Financial Officer | C-Level | $218.75K | $87.50K | $0 | $40.68K | $0 | $30.85K | $377.78K |
Sum of disclosed compensation by year (USD million)
Top founder/C-level executives over time (USD million)